Comparing and Evaluating Five-Day Chemotherapy Agents Actinomycin D and Methotrexate in Low-Risk Post-Molar Gestational Trophoblastic Neoplasia: A Retrospective Analysis
Background: Low-risk post-molar gestational trophoblastic neoplasia is sensitive to chemotherapy, but there is no consensus regarding the best treatment regimen for low-risk post-molar gestational trophoblastic neoplasia. This study aimed to assess the efficacy, toxicity and cost-effectiveness of ac...
Saved in:
Main Authors: | Juan Xu (Author), Xinmei Wang (Author), Pengpeng Qu (Author) |
---|---|
Format: | Book |
Published: |
IMR Press,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women
by: Elza Maria Hartmann Uberti, et al.
Published: (2015) -
Resistance to Single-agent Chemotherapy for Low-risk Gestational Trophoblastic Neoplasia
by: Shahrzad Sheikhhasani, et al.
Published: (2023) -
Comparison between single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
by: Leila Mousavi Seresht, et al.
Published: (2023) -
Assessment of risk factors associated with post-molar gestational trophoblastic neoplasia: a retrospective cohort
by: Silvia Regina Piazzetta, et al.
Published: (2024) -
The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia
by: Yuanyuan Liu, et al.
Published: (2023)